ASND - Financial Reports List - Ascendis Pharma A/S - IntrinsicAlpha

Ascendis Pharma A/S ASND

Healthcare - Biotechnology - NASDAQ - DK

$ 156.78

-2.36 %

$ 9.38 B

Market Cap

-21.84

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	26.30%	55.72%	101.05%
Annual Report	FY	10-K	2024-12-31	36.34%	21.47%	38.81%
Quarterly Report	Q3	8-K	2024-09-30	20.40%	38.85%	28.02%
Quarterly Report	Q2	8-K	2024-06-30	-24.04%	9.93%	5.38%
Quarterly Report	Q1	8-K	2024-03-31	185.49%	-18.14%	65.80%
Quarterly Report	Q4	8-K	2023-12-31	501.42%	58.11%	75.16%
Annual Report	FY	10-K	2023-12-31	421.20%	17.45%	18.92%
Quarterly Report	Q3	8-K	2023-09-30	214.15%	3.98%	6.99%
Quarterly Report	Q2	8-K	2023-06-30	669.37%	-49.33%	0.74%
Quarterly Report	Q1	8-K	2023-03-31	391.93%	11.62%	-12.23%

1